Systematic Review and Network Meta-Analysis Comparing the Efficacy of Fezolinetant With Hormone and Nonhormone Therapies for Treatment of Vasomotor Symptoms Due to Menopause
The neurokinin 3 receptor antagonist fezolinetant 45 mg/d significantly reduced frequency...
Study data suggest that fezolinetant represents the most effective non-HT option for women who have contraindications for HT or wish not to use HT for the treatment of moderate to severe VMS due to menopause.
Share
"I Can't Be Dealing With This Brain Fog": a Workplace Focus Group Study Investigating Factors Underpinning the Menopausal Experience for NHS Staff
Source : https://pubmed.ncbi.nlm.nih.gov/38029510/
Employers have a key role in supporting their staff experiencing menopausal symptoms, and such support has the potential to reduce sickness absence and boost retention.
Menopause symptom experience in the workplace was multifaceted and varied, depending on factors such as medical history, expectations, social support and effectiveness of management strategies.
Share
Concurrent Uterine Surgery and Uptake of Hormone Therapy in Patients Undergoing Bilateral Salpingo-Oophorectomy for Risk-Reducing or Therapeutic Indications
Source : https://pubmed.ncbi.nlm.nih.gov/37988946/
Rates of hysterectomy declined over the study period and slightly more than one-third of eligible patients utilized post-operative HT. Further research on concurrent uterine surgery is needed to establish standardized...
Utilization of concurrent uterine surgery at the time of risk-reducing or therapeutic bilateral salpingo-oophorectomy varies.
Share
Psychometric Evaluation of the PROMIS SD-SF-8b Instrument in Individuals Experiencing Vasomotor Symptoms Due to Menopause
Source : https://pubmed.ncbi.nlm.nih.gov/37990323/
ClinicalTrials.gov numbers: NCT04003155 and NCT04003142.
The psychometric properties of the PROMIS SD-SF-8b support its use to measure sleep disturbance in women with vasomotor symptoms due to menopause.
Share
Menopause has minimal effect on the physiological responses to hypoxia in physically fit women and does not increase the risk of acute mountain sickness. Postmenopausal women have an increased risk of urinary tract infections, which may be exacerbated during mountain travel.
Share